RecruitingNCT06746766

Registry Study on Rare Cancers in Korea


Sponsor

Yonsei University

Enrollment

500 participants

Start Date

Nov 18, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to determine the participation rate of patients with registered rare cancers in clinical research.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study in Korea that collects data on patients with rare cancers — unusual cancer types that are not commonly encountered — to better understand how these cancers behave and how they are treated in real-world clinical settings. **You may be eligible if...** - You are 19 years or older - You have been diagnosed with a rare cancer (as defined by Korean clinical guidelines) - Your life expectancy is at least 3 months **You may NOT be eligible if...** - You have serious, unstable medical or psychiatric conditions that prevent safe participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Severance Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06746766


Related Trials